← Back to Patent Explorer
US4806621A Expired / Lapsed US ⏱️ 0.0 years remaining

Biocompatible, bioerodible, hydrophobic, implantable polyimino carbonate article

Assignee: Massachusetts Institute of Technology
•
Filing: 1986-01-21
•
Granted: 1989-02-21
•
Expires: 2006-01-21
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A novel series of articles useful as medical devices, implants and protheses are provided which utilize poly(iminocarbonate) polymeric matrices. These articles are biocompatible, have excellent mechanical properties and degrade into non-toxic residues after introduction in vivo. The articles may be formed in any desired dimensions and configuration and may take specific shape as biodegradable sutures or as orthopedic appliances such as bone plates and the like.

Inventors

  • 👤 Joachim Kohn
  • 👤 Robert S. Langer

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 11:41
CPC Classifications
C; C08; C08G; C08G64/00; C08G64/04; C08G64/06; C08G64/08; C08G64/12; A; A61; A61L; A61L17/00; A61L17/06; A61L17/10; A61L27/00; A61L27/14; A61L27/18; A61L31/00; A61L31/04; A61L31/06

Claims Analysis

Total Claims: 9
Claim 1
Independent Claim 59 words
An article useful for implantation in an animal comprising a mixture of (a) a solid biocompatible, bioerodible, hydrophobic polyiminocarbonate composition having the recurring structrual unit: ##STR8## wherein R is a divalent aromatic group comprising a non-fused ring and n is at least 2, said article degrading into non-toxic residues after introduction in vivo and (b) a pharmacologically active composition.
Claim 2
Dependent Claim 59 words
An article useful for implantation in an animal comprising a mixture of (a) a solid biocompatible, bioerodible, hydrophobic polyiminocarbonate composition having the recurring structrual unit: ##STR8## wherein R is a divalent aromatic group comprising a non-fused ring and n is at least 2, said article degrading into non-toxic residues after introduction in vivo and (b) a pharmacologically active composition.
Claim 3
Dependent Claim 10 words
The article recited in claim 1 wherein R is phenylene.
Claim 4
Dependent Claim 10 words
The article recited in claim 1 wherein R is: ##STR9##
Claim 5
Dependent Claim 11 words
The article as recited in claim 1 wherein R is: ##STR10##
Claim 6
Dependent Claim 18 words
The article as recited in claim 1 wherein R is: ##STR11## and R' is C,-C 6 lower alkylene.
Claim 7
Dependent Claim 21 words
The article of claim 1 wherein R is: ##STR12## X is a heteroatom and n is an integer greater than 1.
Claim 8
Dependent Claim 9 words
The article of claim 1 wherein R is: ##STR13##
Claim 9
Dependent Claim 32 words
The process for administering a pharmacologically active composition to an animal which comprises implanting in said animal the article of any one of claims 2, 3, 4, 5, 6, 7 or 1.

References Cited (Backward Citations)

US3491060A Cited
US3887699A Cited
US4419340A Cited
US4554155A Cited
US4131648A Cited
US4122158A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1992-02-21 1992-08-22 1993-02-21 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1996-02-21 1996-08-22 1997-02-21 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2000-02-21 2000-08-22 2001-02-21 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag